The concussion of the concept stock of New Crown Pharmaceuticals has led to a rise in Tuoxin Pharmaceutical Industry by more than 10%.

FAP, 24 Apr (Xinhua)-- Tuoxin Pharmaceutical rose more than 10 percent, while Hanyu Pharmaceutical, Panlong Pharmaceutical, Guangshengtang, and Xinhua Pharmaceutical rose more than 5 percent. Public Health Pharmaceutical, Haichen Pharmaceutical, Jincheng Pharmaceutical, essence Pharmaceutical, etc.